(Q38045627)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22999864%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Biology and clinical implications of CD133(+) liver cancer stem cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22999864%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

main subject

neoplastic stem cells

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22999864%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Stephanie Ma

series ordinal

1

1 reference

27 August 2017

language of work or name

English

0 references

publication date

19 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22999864%20AND%20SRC:MED&resulttype=core&format=json

Experimental Cell Research

13 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22999864%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

319

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22999864%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22999864%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

126-132

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22999864%20AND%20SRC:MED&resulttype=core&format=json

CD133: molecule of the moment

13 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.007

Characterization of a side population of cancer cells from human gastrointestinal system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.007

Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.007

Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.007

CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.007

Identification and characterization of tumorigenic liver cancer stem/progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.007

miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.007

CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.007

CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.007

EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.007

The critical role of CD133(+)CD44(+/high) tumor cells in hematogenous metastasis of liver cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.007

CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.007

CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.007

Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.007

Cytoplasmic expression of CD133 is an important risk factor for overall survival in hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.007

Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.007

Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.007

Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.007

Transient mTOR inhibition facilitates continuous growth of liver tumors by modulating the maintenance of CD133+ cell populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.007

BMP4 administration induces differentiation of CD133+ hepatic cancer stem cells, blocking their contributions to hepatocellular carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.007

Expression of CD133 confers malignant potential by regulating metalloproteinases in human hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.007

Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.007

Elevated expression of the stem cell marker CD133 associated with Line-1 demethylation in hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.007

Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.007

Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.007

COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.007

C-terminal truncated hepatitis B virus x protein is associated with metastasis and enhances invasiveness by C-Jun/matrix metalloproteinase protein 10 activation in hepatocellular carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.007

CD133-positive hepatocellular carcinoma in an area endemic for hepatitis B virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.007

Lupeol targets liver tumor-initiating cells through phosphatase and tensin homolog modulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.09.007

10.1016/J.YEXCR.2012.09.007

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22999864%20AND%20SRC:MED&resulttype=core&format=json

release_l5mpht26fzgozftqav5ql3ghli

13 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/l5mpht26fzgozftqav5ql3ghli

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference